Chemours Q3 adjusted profit misses estimates despite titanium pricing gains
CC•Chemours reported Q3 sales of $1.54 billion and adjusted EPS of $0.21, below the $0.27 estimate, while adjusted EBITDA of $200 million beat estimates. It forecasts Q4 adjusted EBITDA of $160 million to $185 million and 2026 adjusted EBITDA of $775 million to $800 million.
1. Quarterly results
Chemours’ Q3 sales rose 3% year over year to $1.54 billion, slightly above the $1.53 billion estimate. Adjusted EPS was $0.21, below the $0.27 estimate, while adjusted EBITDA of $200 million beat the $193.59 million estimate. Adjusted net income of $31 million also missed the $43.21 million estimate.
2. Drivers and outlook
Higher Titanium Technologies pricing and a favorable mix shift toward Advanced Performance Materials’ Performance Solutions drove sales growth. Lower North American stationary air-conditioning aftermarket sales weighed on Thermal & Specialized Solutions volumes, while data center and semiconductor demand supported Performance Solutions. Chemours expects Q4 net sales to decline 5% to 10% sequentially and forecasts adjusted EBITDA of $160 million to $185 million for Q4 and $775 million to $800 million for 2026.
